Modeling human early otic sensory cell development with induced pluripotent stem cells

Area of Science:

• Stem cell biology
• Developmental biology
• Otic development

Background:

• The inner ear is a target for cell-based therapies using human induced pluripotent stem cells (hiPSCs).
• Notch signaling is crucial for specifying the otic region and determining cell fate during ear development.
• Efficient generation of otic progenitors from hiPSCs is needed for research and therapeutic applications.

Purpose of the Study:

• To optimize hiPSC differentiation for generating otic progenitors and sensory cells.
• To investigate the role of Notch signaling modulation in promoting otic sensory lineage development.

Main Methods:

• hiPSCs were cultured and induced towards otic/placodal progenitors using FGF3/FGF10 for 13 days.
• Progenitors were subsequently treated with retinoic acid (RA) and epidermal growth factor (EGF) or a Notch inhibitor for 7 days.
• Gene and protein expression of otic/placodal and sensory markers were analyzed using qPCR and immunocytochemistry.

Main Results:

• hiPSC differentiation upregulated otic/placodal markers after 13 days.
• Notch inhibition significantly increased the percentage of cells expressing key otic sensory markers compared to RA/EGF treatment.
• hiPSC-derived cells showed enhanced expression of otic sensory lineage genes under Notch modulation.

Conclusions:

• Modulating the Notch pathway during in vitro differentiation is a viable strategy to enhance human otic sensory lineage gene expression.
• This approach holds promise for generating a sufficient supply of otic cells for research and cell-based therapies.
• Optimized hiPSC differentiation protocols can advance inner ear regenerative medicine.